PNC Financial Services Group
CTKB icon

PNC Financial Services Group’s Cytek Biosciences CTKB Stock Holding History

PNC Financial Services Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.96K Sell
2,022
-15,905
-89% -$67.9K ﹤0.01% 4141
2026
Q1 		$78.3K Buy
17,927
+1,590
+10% +$7.51K ﹤0.01% 2969
2025
Q4 		$82.5K Sell
16,337
-987
-6% -$4.58K ﹤0.01% 2926
2025
Q3 		$60.1K Buy
17,324
+846
+5% +$3.18K ﹤0.01% 3100
2025
Q2 		$56K Buy
16,478
+12,662
+332% +$42.2K ﹤0.01% 3047
2025
Q1 		$15.3K Sell
3,816
-5,034
-57% -$26.1K ﹤0.01% 3660
2024
Q4 		$57.4K Buy
8,850
+4,665
+111% +$27.8K ﹤0.01% 3023
2024
Q3 		$23.2K Sell
4,185
-2,587
-38% -$14.7K ﹤0.01% 3441
2024
Q2 		$37.8K Buy
6,772
+3,024
+81% +$18.2K ﹤0.01% 3164
2024
Q1 		$25.1K Sell
3,748
-2,347
-39% -$18.6K ﹤0.01% 3331
2023
Q4 		$55.6K Sell
6,095
-2,267
-27% -$14.3K ﹤0.01% 2917
2023
Q3 		$46.2K Buy
8,362
+1,150
+16% +$9.22K ﹤0.01% 3002
2023
Q2 		$61.6K Buy
7,212
+6,777
+1,558% +$60.8K ﹤0.01% 2932
2023
Q1 		$4K Hold
435
– – ﹤0.01% 4108
2022
Q4 		$4.44K Hold
435
– – ﹤0.01% 4026
2022
Q3 		$6K Hold
435
– – ﹤0.01% 3914
2022
Q2 		$5K Hold
435
– – ﹤0.01% 3986
2022
Q1 		$5K Hold
435
– – ﹤0.01% 3989
2021
Q4 		$7K Buy
+435
New +$9.11K ﹤0.01% 3871

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PNC Financial Services Group's CTKB Position: Q2 2026 in Review

PNC Financial Services Group reduced its Cytek Biosciences (CTKB) stake by 89% in Q2 2026, selling an estimated $67.9K and leaving 2,022 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

PNC Financial Services Group first reported a position in CTKB in Q4 2021 and has held it in 19 quarters since. The position peaked at $82.5K in Q4 2025. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • PNC Financial Services Group held 2,022 shares of Cytek Biosciences worth $8.96K as of Q2 2026.
  • PNC Financial Services Group sold 15,905 Cytek Biosciences shares in Q2 2026, an estimated $67.9K.
  • Cytek Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4141 holding.
  • PNC Financial Services Group first reported a position in Cytek Biosciences in Q4 2021 and has held it in 19 quarters since.
  • PNC Financial Services Group's Cytek Biosciences position peaked at $82.5K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.